Evidence map

ArticlePharmaceutics2022

New Data for Nebivolol after In Silico PK Study: Focus on Young Patients and Dosage Regimen.

Lara Marques et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36145659